# Stability indicating green HPLC method for Imeglimin hydrochloride determination in pharmaceutical tablets with comprehensive assessment

**Authors:** Fotouh R. Mansour, Samar H. Elagamy, Almoataz Bellah B. Elbastawissy, Samah F. EL-Malla

PMC · DOI: 10.1038/s41598-025-32999-4 · Scientific Reports · 2026-01-10

## TL;DR

This paper presents a green HPLC method for accurately measuring imeglimin hydrochloride in pharmaceutical tablets, ensuring stability and specificity.

## Contribution

The study introduces a validated and environmentally friendly HPLC method for imeglimin hydrochloride with metformin interference.

## Key findings

- The HPLC method effectively separates and quantifies imeglimin hydrochloride in the presence of metformin.
- The method is specific, with no interference from excipients or degradation products.
- The developed method is environmentally friendly and suitable for in vitro dissolution testing.

## Abstract

In this study, an ion pair RP-HPLC method has been developed for separation and quantification of imeglimin hydrochloride (IMG) in the existence of its processing impurity, metformin hydrochloride (MTF). The chromatographic analysis was performed using an XTerra® RP8 column (5 μm, 150 × 4.6 mm) with a mobile phase consisting of a filtered and degassed mixture of 0.1% 1-octane sulfonic acid sodium salt and absolute ethanol (80:20, %v/v) at a constant flow rate of 1 mL/min. Detection was performed at 241 nm using a photo diode array (PDA) detector. The method parameters were thoroughly evaluated and validated in accordance with ICH Q2 (R2) guidelines. Linearity was established over the range of 0.4–96.0 µg. mL− 1. The use of ion pairing with octane sulfonic acid and ethanol as the mobile phase was effective in achieving an acceptable retention time for the determination of IMG in the presence of metformin and IMG degradation products. Peak purity analysis using PDA detector confirmed that degradation products did not interfere with IMG detection. Furthermore, the method was successfully applied for the accurate quantification of IMG in tablet dosage form, with no interference from excipients, confirming its specificity. Additionally, it was effectively utilized for in vitro dissolution testing of IMG in tablet form, following FDA guidelines. The greenness and applicability of the developed method were assessed using various tools such as the Analytical Eco-Scale, AGREE, MOGAPI, CAFRI, CACI and BAGI demonstrating its environment friendly nature and practicality.

The online version contains supplementary material available at 10.1038/s41598-025-32999-4.

## Linked entities

- **Chemicals:** Imeglimin hydrochloride (PubChem CID 10176486), Metformin hydrochloride (PubChem CID 14219), 1-octane sulfonic acid sodium salt (PubChem CID 23669624), ethanol (PubChem CID 702)

## Full-text entities

- **Chemicals:** ethanol (MESH:D000431), MTF (MESH:D008687), 1-octane sulfonic acid sodium salt (MESH:C042005), IMG (-)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12796370/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12796370/full.md

## References

9 references — full list in the complete paper: https://tomesphere.com/paper/PMC12796370/full.md

---
Source: https://tomesphere.com/paper/PMC12796370